Abstract
Aims and Objective: The common disease of insomnia has complex and diverse clinical manifestations. Lavender represents an effective treatment of insomnia, but the molecular mechanism underlying the effectiveness of this treatment is not clear. The purpose of this study is to investigate the active components, target proteins and molecular pathways of lavender in the treatment of insomnia, thus explaining its possible mechanism.
Materials and Methods: Firstly, 54 active components of lavender were identified by gas chromatography-mass spectrometry (GC-MS). The target protein of lavender was predicted by the Traditional Chinese Medicine System Pharmacological Database and Analysis Platform and the SwissTargetPredicating tool, and the target protein of insomnia was predicted by the DisGeNET and DrugBank databases. Then, the "component-target-disease" network diagram was constructed using the Cytoscape 3.7.1 software. KEGG and GO enrichments were analyzed using the R statistical language. Finally, the key target proteins were verified by collecting and verifying the target protein GEO data using the Discovery Studio 3.5 molecular docking verification software.
Results: 906 target proteins of lavender were predicted by the Traditional Chinese Medicine System Pharmacological Database and Analysis Platform and the SwissTargetPredicating tool, and 182 insomnia target proteins were predicted by the DisGeNET and DrugBank databases. The results of GO enrichment analysis showed that it included the reaction process of ammonium ion, the regulation of the membrane potential and the secretion of catecholamine, while the results of KEGG enrichment included the calcium signaling pathway, serotonin synapse, morphine addiction and many more. Finally, using the Discovery Studio3.5 molecular docking verification software, it was verified that the key target proteins are ADRB1 and HLA-DRB1.
Conclusion: The components in the lavender essential oil include the Ethyl 2-(5-methyl-5-vinyltetrahydrofuran- 2-yl)propan-2-ylcarbonate (0.774); 5-Oxatricyclo[8.2.0.04,6]dodecane, 4,12,12-trimethyl- 9-methylene-, (1R,4R,6R,10S)-(0.147); P-Cymen-7-ol (0.063); .alpha-Humulenem (0.317); Acetic acid, hexyl ester (1.374); etc. The role lavender plays in the treatment of insomnia might be accomplished through the regulation of the key targets ADRB1 and HLA-DRB1.
Keywords: Network pharmacology, lavender, insomnia, target proteins, geodata, molecular docking.
[http://dx.doi.org/10.1016/j.bbr.2011.05.014] [PMID: 21641938]
[http://dx.doi.org/10.1038/nbt1007-1110] [PMID: 17921993]
[http://dx.doi.org/10.1016/j.biopha.2019.109367] [PMID: 31545276]
[http://dx.doi.org/10.1038/nchembio.118] [PMID: 18936753]
[http://dx.doi.org/10.1016/j.supflu.2012.06.008]
[http://dx.doi.org/10.1186/1758-2946-6-13] [PMID: 24735618]
[http://dx.doi.org/10.1093/bioinformatics/btt540] [PMID: 24048355]
[http://dx.doi.org/10.1073/pnas.0506580102] [PMID: 16199517]
[http://dx.doi.org/10.1038/ng1180] [PMID: 12808457]
[http://dx.doi.org/10.1101/gr.1239303] [PMID: 14597658]
[http://dx.doi.org/10.1152/physiolgenomics.00058.2012] [PMID: 22947657]
[http://dx.doi.org/10.5665/sleep.4064]
[http://dx.doi.org/10.1007/s00044-018-2215-8]
[http://dx.doi.org/10.1016/j.jep.2009.02.027] [PMID: 19429342]
[http://dx.doi.org/10.1016/S0893-133X(99)00009-3] [PMID: 10432485]
[http://dx.doi.org/10.1186/1471-2202-8-15] [PMID: 17316437]
[http://dx.doi.org/10.1016/0006-8993(93)90686-H] [PMID: 8448668]